CARVER KYLE (Chief Financial Officer) reported 1 transaction at EVOMMUNE, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 11/12/2025ACC: 0001757072-25-000008
Officer· Chief Financial Officer
Since Nov 2025
-21.82K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.17K acquired · 25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.17K
Price / share
—
Trade value
—
% of position
4.4%
11/7/2025
72.63K→75.80K
Total
Net shares
+3.17K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/7/2025 | C · Conversion | +3.17K | — | — | 4.4% | 72.63K | 75.80K |
| Total | +3.17K | $0.00 | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
3.17K shares
Shares
−25K
Strike price
Held after
0.00
Exercisable
—
11/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock3.17K shares | 11/7/2025 | C · Conversion | −25K | — | 0.00 |